This is suggested by the decrease in CD49f+ population, lower capability to form primary tumor spheres, and smaller side population, as these in vitro properties have all been demonstrated to be associated with CSC phenotype [9, 22, 23, 30, 34]. The gene discussed is ITGA6; the disease is neoplasm.